e-ESO Podcasts

143 Episodo

1. Immunotherapy rechallenge in NSCLC

   Publicado: 3/3/2022
2. ESO’s career development programme

   Publicado: 24/2/2022
3. Summary/Review - Reporting Guidelines - CONSORT

   Publicado: 17/2/2022
4. Summary/Review: Long-term results of SNB after NCT for primary cN1/2 breast who convert to cN0

   Publicado: 10/2/2022
5. Summary/Review: Pathology after neoadjuvant treatment for breast cancer – How to assess residual disease.

   Publicado: 3/2/2022
6. Intraoperative breast ultrasound

   Publicado: 27/1/2022
7. Summary/Review - Reporting Guidelines - PRISMA 2020

   Publicado: 20/1/2022
8. Summary/Review - The use of Artificial Intelligence in the Oncology field. Addressing all the hype and skepticism.

   Publicado: 13/1/2022
9. Advanced Gastric Cancer

   Publicado: 9/12/2021
10. PARP inhibitors for the treatment of ovarian cancer

    Publicado: 2/12/2021
11. The role of clinician-scientists in modern oncology

    Publicado: 25/11/2021
12. Pharmacologic interactions with new drugs

    Publicado: 18/11/2021
13. Positive Resection Margins in Colon Cancer

    Publicado: 11/11/2021
14. Immunotherapy in Lung Cancer

    Publicado: 4/11/2021
15. Low HR positive breast cancer

    Publicado: 28/10/2021
16. Possibilities of tackling side effects of cancer therapies

    Publicado: 21/10/2021
17. Fertility preservation in young cancer patients

    Publicado: 14/10/2021
18. CDK4/6i in HR+HER2- breast cancer

    Publicado: 7/10/2021
19. Treatment selection in castration-resistant prostate cancer

    Publicado: 30/9/2021
20. Questions and Controversies in Localized Head and Neck Cancer

    Publicado: 23/9/2021